Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Actual shortage | 2024-04-11 | 2024-04-11 | 224895 |
TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2018-12-04 | 2019-04-11 | 68619 |
TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-07-02 | 2019-11-01 | 88174 |
TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-12-19 | 2021-09-10 | 101725 |
TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2017-08-01 | 2017-09-19 | 17839 |
TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2019-10-24 | 2019-11-28 | 97153 |
TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2020-04-10 | 2021-03-04 | 111865 |
TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2020-07-14 | 2020-07-15 | 120235 |
TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2020-09-22 | 2021-03-04 | 124743 |
TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2021-03-11 | 2021-05-06 | 135555 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
RAMIPRIL-HCTZ | Discontinued | 2018-12-21 | 2018-12-22 | 70392 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 |